COMPARISONS

How ClaimBack Compares

Honest, side-by-side comparisons with other insurance appeal services. We believe in transparency โ€” see the facts and decide for yourself.

Detailed Comparisons

Click into any comparison to see a full side-by-side breakdown with pricing, features, and FAQs.

VS CLAIMABLE

ClaimBack vs Claimable

Claimable charges $39.95 per appeal and is available only in the United States. ClaimBack offers AI-generated appeal letters from $12 and works in 100+ countries.

โœ“
70% lower cost ($12 vs $39.95)
โœ“
Available in 100+ countries vs US-only
โœ“
AI-powered with jurisdiction-specific citations
Read full comparison โ†’
VS DONOTPAY

ClaimBack vs DoNotPay

DoNotPay is a general-purpose consumer rights tool with a $36/3-month subscription. ClaimBack is purpose-built for insurance appeals with a one-time $12 payment and no subscription required.

โœ“
No subscription required (one-time $12)
โœ“
Purpose-built for insurance claims
โœ“
Transparent AI capabilities
Read full comparison โ†’
VS WAYSTAR

ClaimBack vs Waystar

Waystar is built for hospital systems with contracts starting at $50,000/year and 3โ€“6 month implementations. ClaimBack is built for independent and group practices at $49/month, set up in 5 minutes.

โœ“
From $49/mo vs $50,000+/year enterprise pricing
โœ“
5-minute setup vs 3โ€“6 month implementation
โœ“
Purpose-built for independent & group practices
Read full comparison โ†’
VS AVAILITY

ClaimBack vs Availity

Availity is owned by a consortium of major health insurers, creating a conflict of interest when fighting denials. ClaimBack is fully independent with no payer ownership and generates complete appeal letters in 3 minutes.

โœ“
Fully independent โ€” no payer ownership
โœ“
AI-generated appeal letters vs workflow tracking
โœ“
Supports 100+ countries vs US-primarily
Read full comparison โ†’
VS MD CLARITY

ClaimBack vs MD Clarity

MD Clarity focuses on underpayment recovery and contract analytics. ClaimBack focuses on denial appeal letter generation. Different problems, different tools โ€” here is how they compare.

โœ“
Denial appeals vs underpayment analytics
โœ“
From $49/mo vs $20,000+/year custom pricing
โœ“
AI-generated letters vs workflow identification
Read full comparison โ†’
VS RIVET HEALTH

ClaimBack vs Rivet Health

Rivet Health is a patient collections and price transparency platform. ClaimBack is a denial appeal automation tool. Different points in the revenue cycle โ€” here is how they compare for denial management.

โœ“
Denial appeal generation vs patient collections
โœ“
AI-written letters vs denial tracking workflow
โœ“
100+ countries vs US-only coverage
Read full comparison โ†’

Why People Choose ClaimBack

Four reasons ClaimBack stands out from other insurance appeal services

💰

Simple, Fair Pricing

$12 per appeal letter. No subscription, no hidden fees, no auto-renewal. You pay once for your complete, regulation-ready appeal letter.

🌐

100+ countries

Most competitors focus exclusively on the United States. ClaimBack generates appeal letters citing the specific insurance regulations for your country, whether that is Singapore, the UK, Australia, Hong Kong, or anywhere else.

3-Minute Generation

Answer a few questions about your denied claim and receive a professional appeal letter in under 3 minutes. No waiting, no scheduling, no back-and-forth.

⚖️

Real Regulations

Every appeal letter cites the actual insurance laws, consumer protection regulations, and ombudsman pathways applicable to your jurisdiction and insurer. Not generic templates.

~60%
of properly filed appeals are overturned
100+
countries supported with local regulations
$12
per appeal letter, no subscription

Ready to Fight Your Denied Claim?

Analyse your denied claim in 3 minutes. Get a professional, regulation-ready appeal letter for $12. No subscription, no hidden fees.

Start My Free Analysis

No login required. No credit card. Takes about 3 minutes.

ClaimBack provides AI-assisted document drafting. We are not a law firm and do not provide legal advice. All competitor information is based on publicly available data and may change.